•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

L&L, Indus, S&R, W&C, Freshfields help Carlyle divest $100m in Metropolis Healthcare via BSE block trade

CA Lotus Investments, an investment arm of Carlyle group, sold 65.51 lakh shares of Metropolis Healthcare through a bulk deal on the BSE. The offer size is 13.06 per cent of the outstanding share capital of Metropolis. Currently, CA Lotus holds 71.79 lakh shares or 14.31 per cent stake in the company.

Hindu Business Line

Goldman Sachs (India) Securities Private Limited was one of the brokers to the block trade.

L&L Partners advised the sellers, the Carlyle Group‘s CA Lotus Investments, led by a team including partners Bikash Jhawar and Jitesh Shahani assisted by managing associates Avinash Subramanian and Murtaza Zoomkawala.

White & Case advised the Carlyle Group on non-Indian legal aspects.

IndusLaw advised Goldman Sachs (India) Securities Private Limited led by a team of partner Manan Lahoty, partner Manshoor Nazki and associate Mansi Jhaveri.

Freshfields Bruckhaus Deringer partners Arun Balasubramanian and Robert Zehbe advised Goldman Sachs on non-Indian laws.

Update 16 April 2020: S&R Associates advised Citibank, which acted as broker to Carlyle, led by a team including partner Sudip Mahapatra and associate Abhiroop Dutta.


Deal value: $100m

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click to show 7 comments
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.